RNS: various academic conferences16 Dec 2019 14:21
From the RNS:
The results, along with a full statistical and scientific analysis, will be submitted to the relevant regulatory authorities as is required, at which point the detailed results will be made publicly available. However, in the interim, it is intended that the trial's preliminary observations may be presented at various academic conferences, as part of the compound's ongoing reporting and analysis.
Does this mean that they need to spend money attending 'various academic conferences' to publicise the 'limited preliminary observations [that] can be inferred. Do they have the funds to do this? They have little headroom to place without calling an EGM to approve issuing more shares.
Cash is King... And currently Investors have not been shown where the cash comes from other than placing more shares.
I like the science but the funding model does not seem to currently help investors.